Sertraline

• A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised
  2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
• Clinical trial to evaluate the effectiveness and efficiency of a pre-emptive pharmacogenetic strategy for antidepressant selection in patien… Pending
  2025-522967-13-00 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared… Recruiting
  2023-506605-19-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
• Selective serotonin reuptake inhibition in patients with advanced gastroesophageal cancer receiving immunochemotherapy: a prospective phase … Recruiting
  2024-518631-11-00 Phase II 1 country Medical University Of Vienna
• "SAFE DISCONTINUATION OF ANTIDEPRESSANTS IN INDIVIDUALS WITH CLINICALLY REMITTED DEPRESSIVE DISORDERS" Recruiting
  2023-509377-23-00 Phase IV 1 country Universita Degli Studi Di Verona
• A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting
  2023-509680-25-00 Phase IV 3 countries Parnassia Groep B.V.
• The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Cont… Recruiting
  2022-501428-45-00 Phase III 1 country Region Hovedstadens Psykiatriske
• The effect of sertraline on anxiety-depressive symptoms, endothelial dysfunction and biomarkers in heart failure patients with preserved eje… Ended
  2024-515061-33-00 Phase III 1 country Medical University Of Gdansk
• Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended
  2022-500538-27-00 Phase II/III 6 countries Otsuka Pharmaceutical Development And Commercialization Inc.

Showing 1–9 of 9 trials